Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes

Anti-tumor necrosis factor-α (TNFα) therapy has improved the prognosis of many chronic inflammatory diseases. It appears to be well-tolerated by liver-transplant patients. However, their use and their safety in kidney-transplant patients have yet to be determined. In this retrospective study, we ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrouste, Cyril, Anglicheau, Dany, Kamar, Nassim, Bachelier, Claire, Rivalan, Joseph, Pereira, Bruno, Caillard, Sophie, Aniort, Julien, Gatault, Philippe, Soubrier, Martin, Sayegh, Johnny, Colosio, Charlotte, Buisson, Anthony, Thervet, Eric, Bouvier, Nicolas, Heng, Anne Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072954/
https://www.ncbi.nlm.nih.gov/pubmed/27741127
http://dx.doi.org/10.1097/MD.0000000000005108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072954/
https://www.ncbi.nlm.nih.gov/pubmed/27741127
http://dx.doi.org/10.1097/MD.0000000000005108

Ejemplares similares